ArticleVaccine2015

Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.

Justin L Spinner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.